Amateur Radio software for transmission/reception of JT65 protocol. Studies will be needed to confirm this finding.Amateur Radio software for transmission/reception of JT65 protocol on HF bands 2m - 160m Note: The JT65 encoding and decoding routines, also used in WSJT, are developed by K1JT, Joe Taylor. "but the number of patients in this group was small, and larger Statistically lowered the rate of respiratory events, Dr. blocker use in patients who have asthma and COPD Terms of unscheduled office visits, ER visits, or hospitalizations. Overall, the use of -blockers in patients who had asthmaĪnd/or COPD did not increase the number of respiratory encounters in Increase in respiratory encounters, compared with patients who had a Patients with HF and any respiratory diagnosis had a three-fold blockers "that are felt to be safer in patients with In addition, 49% of the patients were prescribed cardioselective About 45% of the asthmatics and 35% of the patients Only 39% of the patients with HF and obstructive lung disease were "So, overall,ġ9.6% of patients had obstructive lung disease and could have benefited The prevalence of asthma was 5.9%, the prevalence of COPD wasġ1.2%, and 2.5% of patients had both COPD and asthma. Hospitalization over the 18-month period to evaluate respiratory Investigators reviewed every nonroutine office visit, ER visit, and Included 1,067 patients with HF who were followed over 18 months. Their retrospective analysis of prospectively collected data Prevalence of respiratory events in patients with COPD and/or asthma. Department of Defense, he and hisĪssociates evaluated the prevalence of -blocker use and the But "the duration of the studies was onlyģ days to 4 weeks, and only 46 patients had pulmonary function Respiratory symptoms or inhaler use, and that -blockers mayĮnhance the effect of inhaled -agonist (Cochrane Database Syst. If the patient has any history of obstructive lung disease," Dr.Ī recent metaanalysis of data on 141 patients concluded thatĬardioselective -blockers are not associated with increased Many physicians in the community are hesitant to use these medications "Unfortunately, many review articles and guidelines often listĪsthma and COPD as relative contraindications to using -blockers. In fact, results of recent studies have shown improved survivalĪmong HF patients on -blockers: For every 20 patients treated with Peters of the division of pulmonary diseases and critical care medicineĪt the University of Texas Health Science Center at San Antonio. receptor and was useful" in patients with HF, said Dr. That the use of cardioselective -blockers upregulated the Mandates their use whenever possible," he said.ĭuring the 1960s, physicians viewed -blockers asĬontraindicated in patients with HF. Mortality benefit of -blocking medication in "We did not see any differences in outcome with the use ofĬardioselective vs. Peters, M.D., said at a press briefing during the annual meeting of the Not increase the risk for respiratory complications," Jay I. Management of, our study found that long-term use did "Although a history of asthma and/or COPD is still consideredĪ relative contraindication to the use of -blockers in the Not increase the risk of respiratory complications, results from a large Patients with chronic obstructive pulmonary disease and/or asthma did SEATTLE - The long-term use of -blockers in heart failure APA style: -blockers appear safe in HF patients who have obstructive lung disease.blockers appear safe in HF patients who have obstructive lung disease." Retrieved from 2004 International Medical News Group 26 Apr.
MLA style: "-blockers appear safe in HF patients who have obstructive lung disease." The Free Library.